Credit Suisse’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-25,000
Closed -$1.77M 4247
2016
Q4
$1.77M Buy
+25,000
New +$1.86M ﹤0.01% 2531
2016
Q2
Sell
-50,000
Closed -$4.25M 4440
2016
Q1
$4.25M Buy
50,000
+40,000
+400% +$2.98M 0.01% 1644
2015
Q4
$790K Buy
+10,000
New +$788K ﹤0.01% 3017
2014
Q4
Sell
-42,600
Closed -$4.1M 4819
2014
Q3
$4.1M Buy
42,600
+35,100
+468% +$3.33M ﹤0.01% 1910
2014
Q2
$699K Sell
7,500
-17,500
-70% -$1.53M ﹤0.01% 3581
2014
Q1
$2.08M Buy
+25,000
New +$2.03M ﹤0.01% 2476

Other funds holding MJN

Credit Suisse's MJN Position: Q2 2017 in Review

Credit Suisse sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 913,279 shares — an estimated $81.4M sold.

Credit Suisse first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $81.4M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Credit Suisse reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Credit Suisse sold 913,279 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $81.4M.
  • Credit Suisse first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Credit Suisse's Mead Johnson Nutrition Company position peaked at $81.4M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.